Sandbox:Amd: Difference between revisions
Jump to navigation
Jump to search
Line 22: | Line 22: | ||
! colspan="6" style="background:#4479BA; color: #FFFFFF;" |Lab findings/Urine exam | ! colspan="6" style="background:#4479BA; color: #FFFFFF;" |Lab findings/Urine exam | ||
|- | |- | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" | | | align="center" style="background:#4479BA; color: #FFFFFF;" |Dysuria | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Nocturia | | align="center" style="background:#4479BA; color: #FFFFFF;" |Nocturia | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" | | | align="center" style="background:#4479BA; color: #FFFFFF;" |Hematuria | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Dribbling | | align="center" style="background:#4479BA; color: #FFFFFF;" |Dribbling | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Proteinuria | | align="center" style="background:#4479BA; color: #FFFFFF;" |Proteinuria | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" | | |||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Edema | | align="center" style="background:#4479BA; color: #FFFFFF;" |Edema | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Serum osmolarity | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Urine Na | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Urine Na | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Proteins | | align="center" style="background:#4479BA; color: #FFFFFF;" |Proteins | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Urine osmolarity | | align="center" style="background:#4479BA; color: #FFFFFF;" |Urine osmolarity | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" | | | align="center" style="background:#4479BA; color: #FFFFFF;" | | ||
| align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard | | align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard | ||
Line 59: | Line 59: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 138: | Line 138: | ||
! | ! | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center"|[[Nephrogenic diabetes insipidus]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Nephrogenic diabetes insipidus]] | ||
! | ! | ||
! | ! | ||
Line 155: | Line 155: | ||
|- | |- | ||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Renal disease | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Renal disease | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center"|[[Renal tubular acidosis]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Renal tubular acidosis]] | ||
! | ! | ||
! | ! | ||
Line 171: | Line 171: | ||
! | ! | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center"|[[Bartter syndrome]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Bartter syndrome]] | ||
! | ! | ||
! | ! |
Revision as of 14:55, 9 May 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Differential diagnosis
Abbreviations:
POLYURIA
Mechanism | Etiology | Clinical manifestations | Paraclinical findings | Comments | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms and signs | Lab findings/Urine exam | |||||||||||||||
Dysuria | Nocturia | Hematuria | Dribbling | Proteinuria | Edema | Serum osmolarity | Urine Na | Proteins | Urine osmolarity | Gold standard | ||||||
Increased intake of fluid | Psychogenic polydipsia | – | – | |||||||||||||
Increased solute excretion | Osmotic causes | Diabetes mellitus | + | + | ||||||||||||
Mannitol | ||||||||||||||||
Salt loss | Diuretics | |||||||||||||||
Cerebral salt-wasting syndrome | ||||||||||||||||
Impaired urinary concentration | Low ADH | Central diabetes insipidus | ||||||||||||||
Nephrogenic diabetes insipidus | ||||||||||||||||
Renal disease | Renal tubular acidosis | |||||||||||||||
Bartter syndrome |
Differential diagnosis
Abbreviations: AP= Anteroposterior, CXR= Chest X-ray, CT= Computed tomography, ABG= Arterial blood gas, V/Q= Ventilation/perfusion scan , EKG= Electrocardiogram, COPD= Chronic obstructive pulmonary disease, BNP= Brain natriuretic peptide, DVT= Deep vein thrombosis, HRCT= High Resolution CT, IgE= Immunoglobulin E
|
- ↑ Cherry, James D. (2008). "Croup". New England Journal of Medicine. 358 (4): 384–391. doi:10.1056/NEJMcp072022. ISSN 0028-4793.
- ↑ Khurshid I, Downie GH (2002). "Pulmonary arteriovenous malformation". Postgrad Med J. 78 (918): 191–7. PMC 1742331. PMID 11930021.
- ↑ Doshi HM, Robinson S, Chalhoub T, Jack S, Denison A, Gibson G (2009). "Massive spontaneous hemothorax during the immediate postpartum period". Tex Heart Inst J. 36 (3): 247–9. PMC 2696501. PMID 19568398.
- ↑ Chanatry BJ (1992). "Acute hemothorax owing to pulmonary arteriovenous malformation in pregnancy". Anesth. Analg. 74 (4): 613–5. PMID 1554132.